ArticleOPEN ACCESS

Corrigendum: Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: A short review on the current evidence (Onco Targets Ther, 2019, 12, 3171–3179)

OncoTargets and Therapy
DOI: 10.2147/OTT.S250177
0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Lucio Crinò has advised that affiliation 3 is incorrect. The correct affiliation 3 should be as follows: Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST IRCCS), Meldola, Italy.

Cite

CITATION STYLE

APA

Ricciuti, B., Genova, C., Crinò, L., Libra, M., & Leonardi, G. C. (2020). Corrigendum: Antitumor activity of larotrectinib in tumors harboring NTRK gene fusions: A short review on the current evidence (Onco Targets Ther, 2019, 12, 3171–3179). OncoTargets and Therapy. Dove Medical Press Ltd. https://doi.org/10.2147/OTT.S250177

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free